<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03057925</url>
  </required_header>
  <id_info>
    <org_study_id>wwju127</org_study_id>
    <nct_id>NCT03057925</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules</brief_title>
  <official_title>Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenjun Wu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital of Wenzhou Medical Univeristy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>First Affiliated Hospital of Wenzhou Medical Univeristy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous microwave ablation(MWA) was reported as an effective modality for the management
      of thyroid nodules(TNs). This study aims to validate MWA as a feasible approach for patients
      with TNs for whom surgery is contraindicated or refused. Two groups of subjects with TNs(one
      group to treat with MWA and the other group to receive regular ultrasonic follow-up without
      any treatment) will be evaluated in term of TN volume, ultrasonic image and clinical
      symptoms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the thyroid nodule volume assessed by ultrasonography after treatment vs simple clinical observation</measure>
    <time_frame>From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months</time_frame>
    <description>Change of the thyroid nodule volume assessed by using ultrasonography, the volume reduction ratio(VRR) was calculated by the equation: VRR%=[(initial volume-final volume)*100]/initial volume</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved score on TN-related symptoms</measure>
    <time_frame>From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months</time_frame>
    <description>Evaluation of TN-related neck symptoms scored separately as follow:0(absent),1(moderate),2(severe). The sum of the individual scores generates a final score(SYS score) ranging from 0 to 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved cosmetic grading score</measure>
    <time_frame>From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months</time_frame>
    <description>Cosmetic problem evaluated by grading score(1,no palpable mass;2, no cosmetic problem but palpable mass; 3, a cosmetic problem on swallowing only; and 4, a readily detected cosmetic problem</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MWA Percutaneous Microwave Ablation intervention procedure: Ultrasound-guided Percutaneous Microwave Ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>untreated no treatment; regular ultrasonic image follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Microwave Ablation</intervention_name>
    <description>Ultrasound-guided Percutaneous Microwave Ablation</description>
    <arm_group_label>Group A</arm_group_label>
    <other_name>Ultrasound-guided Percutaneous Microwave Ablation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18 years

          -  benign thyroid nodules(TYP 2)

          -  solid or predominantly solid(colloid component&lt;30%)large (&gt;3.0ml) thyroid nodules

          -  refusal and/or inefficacy of surgery

        Exclusion Criteria:

          -  pregnancy

          -  malignant or suspicious thyroid nodules
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaojun Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thyroid Center of The First Affiliated Hospital of Wenzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zimiao Chen</last_name>
    <phone>86-0577-88069715</phone>
    <email>zimiaochen@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjun Wu</last_name>
      <phone>86-0577-55579381</phone>
      <email>wwju127@126.com</email>
    </contact>
    <investigator>
      <last_name>Xiaojun Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaohua Gong</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qi Zhou</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2017</study_first_submitted>
  <study_first_submitted_qc>February 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2017</study_first_posted>
  <last_update_submitted>June 17, 2017</last_update_submitted>
  <last_update_submitted_qc>June 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Wenzhou Medical Univeristy</investigator_affiliation>
    <investigator_full_name>Wenjun Wu</investigator_full_name>
    <investigator_title>associate chief physician</investigator_title>
  </responsible_party>
  <keyword>thyroid nodule</keyword>
  <keyword>microwave ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

